Don Wright

Don Wright is the founder and CEO of Clarigent Health, triangulating mental health metrics from the patient, the clinician, and the company’s proprietary vocal biomarkers technology. This supports earlier detection of risk, continuous monitoring of progress over time, and group-level insights for mental health care organizations. Prior to Clarigent, Don spent the previous decade developing the GeneSight pharmacogenomics product at Assurex Health helping almost two million people get on the right treatment for depression, anxiety, and other psychiatric conditions. Don is the President of the Suicide Prevention Initiative and Depression Research Foundation. He is also the chairman of Inagene Diagnostics, a pharmacogenomics company specializing in mental health and pain treatment. He is the chairman of the Hamilton Mill a Cincinnati area startup accelerator and a member of the board of advisors of OhioX, the board of advisors of the Xavier University Master of Science in Customer Analytics Program, the NKU Center for Innovation and Entrepreneurship, the University of Cincinnati Technology Accelerator for Commercialization, as well as the Cincinnati Children's Hospital Digital Health and Care committee.